A diabetes drug released in 1995 shows promise of possibly being a cancer-fighting treatment for those in need.
Metformin, which has been on the market for over 7 years, was approved by the FDA to help those with diabetes control their sugar intake. Since its introduction, it has become one of the most widespread drugs used for this purpose. The reason for this is the patent for metformin expired in 2002. This made the drug much cheaper, lowering the cost to a few pennies per pill as generic versions began hitting the market. Continue reading Generic diabetes drug may fight cancer